Menopause Hormone Therapy (HRT) in Noblesville, IN

Bioidentical hormones in Noblesville: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. Neither has to be compounded: FDA-approved estradiol comes as pills, patches, gels, sprays, vaginal creams and rings, and progesterone as capsules.

Only 10 OB-GYNs list a primary practice address in Noblesville in the NPI registry. For 71,940 residents that is 13.9 per 100,000, under the US 17.8 and below Indiana's 16.3. Set against the city's 8,044 women aged 45 to 64, that is one OB-GYN for roughly every 800.

Counting the area around it, 97 OB-GYNs practice in Noblesville or within 10 miles and 397 within 25 miles: 27.4 for every 100,000 of the 1,449,445 people who live within 25 miles, a dense supply. VevaMD is an online option alongside them: a physician licensed in Indiana reviews your intake from Noblesville without an office visit, and an OB-GYN you already see stays your doctor.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

For women in Noblesville, a physician licensed in Indiana can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. Since the pharmacy that fills these prescriptions also compounds, ask whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

BHRT pellet clinics work differently: they place a hormone pellet under the skin in the office, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11